SpringWorks Therapeutics Insider Sold Shares Worth $1,084,592, According to a Recent SEC Filing-June 2024-www.financetom.com

SpringWorks Therapeutics Insider Sold Shares Worth $1,084,592, According to a Recent SEC Filing

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

SpringWorks Therapeutics Insider Sold Shares Worth $1,084,592, According to a Recent SEC Filing

Mar 6, 2025 12:08 AM

02:51 AM EST, 03/06/2025 (MT Newswires) -- Badreddin Edris, Chief Operating Officer, on March 03, 2025, sold 20,000 shares in SpringWorks Therapeutics ( SWTX ) for $1,084,592. Following the Form 4 filing with the SEC, Edris has control over a total of 169,712 common shares of the company, with 169,712 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1773427/000110465925021008/xslF345X05/tm258294-2_4seq1.xml

Previous page： Trump's Tariffs Announcement 'Worse Than the Worst Case Scenario,' Wedbush Says Next page： Traders seek refuge in Aussie consumer staples as US tariffs spark market fall

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Trump's Tariffs Announcement 'Worse Than the Worst Case Scenario,' Wedbush Says

Apr 3, 2025

04:35 AM EDT, 04/03/2025 (MT Newswires) -- The slate of tariffs from the Trump administration is worse than the worst case scenario feared by analysts, according to Wedbush Securities. In a note emailed to clients on Wednesday, Wedbush analysts, led by Daniel Ives, said tech stocks will be under major pressure following the announcement. On Wednesday, the Trump administration unveiled...

Traders seek refuge in Aussie consumer staples as US tariffs spark market fall

Apr 3, 2025

By Rajasik Mukherjee (Reuters) - Shares of Australia's consumer staple companies rose on Thursday, driven by grocers Coles and Woolworths, as investors moved to safer bets after U.S. President Donald Trump's reciprocal tariffs sparked global market turmoil. Shares of the sector ended 1.3% higher while the broader Australian market fell 0.9% to its lowest since March 14. Coles rose 2.1%...

Mesoblast Files Meeting Request With FDA for Ischemic Heart Failure Treatment Candidate

Apr 3, 2025

04:23 AM EDT, 04/03/2025 (MT Newswires) -- Mesoblast (MESO) said late Wednesday it expets to have a type B meeting with the US Food and Drug Administration during the current quarter to discuss the accelerated approval pathway for ischemic heart failure treatment candidate, Revascor. The main goals of the meeting are to get FDA feedback on relevant chemistry, manufacturing &...

Novartis Gets FDA Accelerated Approval for Vanrafia

Apr 3, 2025

04:41 AM EDT, 04/03/2025 (MT Newswires) -- Novartis ( NVS ) said late Wednesday the US Food and Drug Administration granted accelerated approval for Vanrafia to reduce proteinuria in adults with primary immunoglobulin A nephropathy, or IgAN, at risk of rapid disease progression. IgAN is a progressive, rare kidney disease. Data from an ongoing phase III showed that Vanrafia achieved...